苑东生物
(688513)
| 流通市值：112.40亿 | | | 总市值：112.40亿 |
| 流通股本：1.77亿 | | | 总股本：1.77亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 326,009,384.37 | 855,427,501.81 | 584,411,799.85 | 810,266,206.25 |
| 交易性金融资产 | 1,295,520,743.46 | 758,004,625.52 | 981,757,088.22 | 730,156,846.48 |
| 应收票据及应收账款 | 198,596,530.35 | 201,354,482.1 | 233,182,625.51 | 211,016,627.28 |
| 其中：应收票据 | 20,605,823.61 | 20,066,391.24 | 15,124,039.36 | 18,932,630.09 |
| 应收账款 | 177,990,706.74 | 181,288,090.86 | 218,058,586.15 | 192,083,997.19 |
| 应收款项融资 | 14,872,040.03 | 56,425,469.07 | 24,136,781.75 | 22,312,692.96 |
| 预付款项 | 16,962,564.54 | 18,303,828.66 | 17,440,341.18 | 10,483,285.08 |
| 其他应收款合计 | 438,179.08 | 314,711.62 | 532,223.15 | 593,773.78 |
| 存货 | 246,660,479.19 | 228,705,709.64 | 224,831,182.36 | 216,531,218.89 |
| 其他流动资产 | 18,314,362.65 | 13,627,964.14 | 8,877,124.47 | 13,457,874.77 |
| 流动资产合计 | 2,117,374,283.67 | 2,132,164,292.56 | 2,075,169,166.49 | 2,014,818,525.49 |
| 非流动资产: | | | | |
| 长期股权投资 | 22,855,926.86 | 23,212,698.29 | 51,548,771.23 | 22,089,595.79 |
| 其他权益工具投资 | - | - | - | 10,000,000 |
| 其他非流动金融资产 | 54,000,000 | 48,000,000 | 48,000,000 | 48,000,000 |
| 固定资产 | 1,151,496,210.15 | 1,170,462,043.71 | 1,107,386,532.91 | 1,116,107,780.02 |
| 在建工程 | 61,078,928.94 | 53,737,809.31 | 118,497,314.07 | 112,190,863.23 |
| 无形资产 | 202,056,647.16 | 207,013,193.12 | 33,813,647.71 | 34,384,294.06 |
| 开发支出 | 96,581,042.12 | 94,209,256.72 | 85,169,414.74 | 76,784,835.06 |
| 商誉 | 23,099,384.34 | 23,099,384.34 | - | - |
| 长期待摊费用 | 4,484,491.21 | 4,963,359.49 | 4,314,672.9 | 3,153,912.84 |
| 递延所得税资产 | 25,483,933.38 | 23,676,080.3 | 12,855,577.91 | 10,164,165.33 |
| 其他非流动资产 | 18,933,705.73 | 17,341,189.37 | 22,166,935.14 | 14,809,462.01 |
| 非流动资产合计 | 1,660,070,269.89 | 1,665,715,014.65 | 1,483,752,866.61 | 1,447,684,908.34 |
| 资产总计 | 3,777,444,553.56 | 3,797,879,307.21 | 3,558,922,033.1 | 3,462,503,433.83 |
| 流动负债: | | | | |
| 短期借款 | 45,379,472.07 | 110,713,599.13 | 95,075,403.53 | 90,135,831.57 |
| 应付票据及应付账款 | 105,025,049.68 | 124,980,394.29 | 141,912,016.38 | 130,207,281.37 |
| 其中：应付票据 | 34,341,148.81 | 41,586,301.91 | 38,826,377.01 | 28,054,448.65 |
| 应付账款 | 70,683,900.87 | 83,394,092.38 | 103,085,639.37 | 102,152,832.72 |
| 合同负债 | 27,886,774.38 | 23,307,632.19 | 27,659,994.31 | 35,194,682.36 |
| 应付职工薪酬 | 26,241,680.17 | 49,407,102 | 37,607,660.5 | 31,054,896.13 |
| 应交税费 | 29,370,205.3 | 30,580,175.97 | 37,935,825.01 | 21,621,509.21 |
| 其他应付款合计 | 309,815,584.65 | 270,272,142.26 | 241,035,125.72 | 263,442,787.48 |
| 一年内到期的非流动负债 | 4,400,000 | 4,400,000 | 4,400,000 | 4,424,892.59 |
| 其他流动负债 | 5,519,458.72 | 5,035,679.6 | 7,641,317.23 | 5,736,981.61 |
| 流动负债合计 | 553,638,224.97 | 618,696,725.44 | 593,267,342.68 | 581,818,862.32 |
| 非流动负债: | | | | |
| 长期借款 | 31,555,292.58 | 31,533,333.32 | 33,754,518.51 | 33,733,333.32 |
| 递延收益 | 60,825,820.26 | 62,487,374.29 | 63,021,750.1 | 64,652,642.11 |
| 递延所得税负债 | 45,468,032.47 | 46,186,366.18 | 2,897,360.11 | 2,215,580.09 |
| 非流动负债合计 | 137,849,145.31 | 140,207,073.79 | 99,673,628.72 | 100,601,555.52 |
| 负债合计 | 691,487,370.28 | 758,903,799.23 | 692,940,971.4 | 682,420,417.84 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 176,532,256 | 176,532,256 | 176,532,256 | 176,532,256 |
| 资本公积 | 1,406,888,704.83 | 1,403,665,010.02 | 1,399,773,459.84 | 1,399,474,159.32 |
| 减:库存股 | 67,672,535.14 | 67,672,535.14 | 67,672,535.14 | 67,672,535.14 |
| 专项储备 | 1,735,314.62 | 1,259,100.45 | 2,190,411.55 | 1,758,693.53 |
| 盈余公积 | 88,266,128 | 88,266,128 | 79,462,430.94 | 79,462,430.94 |
| 未分配利润 | 1,381,619,264.85 | 1,330,788,242.97 | 1,275,695,038.51 | 1,190,528,011.34 |
| 归属于母公司股东权益合计 | 2,987,369,133.16 | 2,932,838,202.3 | 2,865,981,061.7 | 2,780,083,015.99 |
| 少数股东权益 | 98,588,050.12 | 106,137,305.68 | - | - |
| 股东权益合计 | 3,085,957,183.28 | 3,038,975,507.98 | 2,865,981,061.7 | 2,780,083,015.99 |
| 负债和股东权益合计 | 3,777,444,553.56 | 3,797,879,307.21 | 3,558,922,033.1 | 3,462,503,433.83 |
| 公告日期 | 2026-04-22 | 2026-04-22 | 2025-10-28 | 2025-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |